New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate
- PMID: 33768944
- PMCID: PMC7981715
- DOI: 10.1002/ccr3.3768
New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate
Abstract
The sinoatrial block is a new side effect of meglumine antimoniate. Prompt interruption of the drug results in the normalization of electrographic changes and prevents sudden cardiac arrest.
Keywords: cardiotoxicity; cutaneous leishmaniasis; meglumine antimoniate.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
No conflict of interest.
Figures



References
-
- Matoussi N, Ameur HB, Amor SB, Fitouri Z, Becher SB. Toxicité cardiaque de l’antimoniate de meglumine (Glucantime) à propos d’une obsevation. Med Mal Infect. 2007;37:257‐259. - PubMed
-
- Sundar S, Probhat R, Nutan KA, et al. A cluster of cases of severe cardio toxicity among Kala –Azar patients treated with a high osmolarity lot of sodium antimony gluconate. Am Trop Med Hyg. 1998;59:139‐143. - PubMed
-
- Kuryshev YA, Wang L, Wible BA, Yuri A, Wan X, Ficker E. Antimony‐based anti leishmanial compounds prolong the cardiac action potential by an increase in cardia calcium currents. Mol Pharmacol. 2006;69:1216‐1225. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources